MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

Search

Essa Pharma Inc

Fermé

0.19 -5

Résumé

Variation du prix de l'action

24h

Actuel

Min

0.19

Max

0.19

Chiffres clés

By Trading Economics

Revenu

2.4M

-4M

Rendement du dividende

87.56

Employés

35

EBITDA

1.4M

-5M

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

87.56%

3.00%

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-75M

9.5M

Ouverture précédente

5.19

Clôture précédente

0.19

Score Technique

By Trading Central

Confiance

Bearish Evidence

Essa Pharma Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

19 oct. 2025, 20:00 UTC

Acquisitions, Fusions, Rachats

Infratil Agrees to NZ$437.7 Million Deal to Raise Contact Energy Stake

19 oct. 2025, 23:44 UTC

Market Talk

Gold Edges Lower Amid Signs of U.S.-China Trade Tensions Easing -- Market Talk

19 oct. 2025, 23:37 UTC

Market Talk

New Zealand's Core CPI Keeps Rate Cut Hopes Alive -- Market Talk

19 oct. 2025, 23:36 UTC

Market Talk

Nikkei May Rise, Tracking Wall Street Gains -- Market Talk

19 oct. 2025, 23:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

19 oct. 2025, 23:09 UTC

Market Talk

Could Rio Tinto, BHP Ally to Defend Iron-Ore Pricing Power? -- Market Talk

19 oct. 2025, 22:41 UTC

Acquisitions, Fusions, Rachats

Luxury Fashion House Kering Confirms Beauty Deal With L'Oréal -- Barrons.com

19 oct. 2025, 22:30 UTC

Résultats

Stock Futures Rise Ahead of Major Week of Earnings -- Barrons.com

19 oct. 2025, 22:18 UTC

Market Talk

Gold at $5,000 on Cards as Investors Get Comfortable -- Market Talk

19 oct. 2025, 21:50 UTC

Market Talk

Infratil's Contact Stake Buy May Require Bigger Asset Sales -- Market Talk

19 oct. 2025, 21:15 UTC

Market Talk

Investors Need to Change Narrative Toward Scales -- Market Talk

19 oct. 2025, 19:34 UTC

Acquisitions, Fusions, Rachats

Infratil's Contact Shareholding to Rise to 14.3% When Deal Completes

19 oct. 2025, 19:34 UTC

Acquisitions, Fusions, Rachats

Infratil to Issue New Shares Worth NZ$218.8 Million to TECT at NZ$12.43 Each

19 oct. 2025, 19:33 UTC

Acquisitions, Fusions, Rachats

Infratil Part-Funding Purchase of Contact Energy Stake With NZ$218.8 Million of Existing Debt

19 oct. 2025, 19:32 UTC

Acquisitions, Fusions, Rachats

Infratil Acquiring Additional Contact Energy Stake for NZ$8.95/Share

19 oct. 2025, 19:32 UTC

Acquisitions, Fusions, Rachats

Infratil Acquiring Contact Energy Stake for NZ$437.7 Million

19 oct. 2025, 19:31 UTC

Acquisitions, Fusions, Rachats

Infratil Acquiring TECT Holdings's Shareholding in Contact Energy

19 oct. 2025, 19:31 UTC

Acquisitions, Fusions, Rachats

Infratil to Acquire Additional 4.92% Stake in Contact Energy

19 oct. 2025, 16:29 UTC

Résultats

Elon Musk Pay Drama Heats Up Ahead of Tesla Earnings -- Barrons.com

19 oct. 2025, 11:14 UTC

Résultats

Zijin Mining 3Q Oper Income CNY86.49B; up 8.1% on Year>2899.HK

19 oct. 2025, 11:14 UTC

Résultats

Zijin Mining: Higher Sales of Gold, Copper Supported Results >2899.HK

19 oct. 2025, 11:14 UTC

Résultats

Zijin Mining 3Q Net CNY14.57B; up 57.1% on Year>2899.HK

18 oct. 2025, 13:30 UTC

Acquisitions, Fusions, Rachats

Deal Expected to Value Unit at Roughly $4B, Sources Say -- WSJ

18 oct. 2025, 13:30 UTC

Acquisitions, Fusions, Rachats

Deal Could Be Announced as Soon as Next Week, Sources Say -- WSJ

18 oct. 2025, 13:30 UTC

Acquisitions, Fusions, Rachats

Gucci Owner Kering Nears $4 Billion Sale of Beauty Unit to L'Oréal -- WSJ

18 oct. 2025, 13:30 UTC

Acquisitions, Fusions, Rachats

Gucci Parent Kering in Talks to Sell Beauty Business to L'Oréal, Sources Say -- WSJ

18 oct. 2025, 08:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

17 oct. 2025, 23:25 UTC

Acquisitions, Fusions, Rachats

New Zealand's 'Golden Visa' Targets the Affluent in Search of Plan B -- Barrons.com

17 oct. 2025, 22:15 UTC

Market Talk

Ulta's CFO Appointment Seen Supporting Growth -- Market Talk

17 oct. 2025, 21:15 UTC

Market Talk

Greece Expected to Post Overall Budgetary Surplus This Year -- Market Talk

Comparaison

Variation de prix

Essa Pharma Inc prévision

Note du Consensus

By TipRanks

0 ratings

0

Achat

0

Maintien

0

Vente

Score Technique

By Trading Central

1.7 / 1.72Support & Résistance

Court Terme

Bearish Evidence

Moyen Terme

Bullish Evidence

Long Terme

Weak Bearish Evidence

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Essa Pharma Inc

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.
help-icon Live chat